Skip navigation
Search
Sciety application settings
Home
Groups
Explore
Newsletter
About
Log In
An Engineered Prodrug Selectively Suppresses β-Lactam-Resistant Bacteria in a Mixed Microbial Setting
Addison M. Duda
Helena R. Ma
César A. Villalobos
Sophia A. Kuhn
Sarah S. Angle
Katherine He
Abigail C. Jackson
Christine M. Suh
Elena A. Puccio
Deverick J. Anderson
Vance G. Fowler
Lingchong You
Katherine J. Franz
Read the full article
See related articles
Listed in
This article is not in any list yet, why not save it to one of your lists.
Log in to save this article
Abstract
No abstract available
Article activity feed
Version published to 10.1021/acsinfecdis.5c00179
Jun 12, 2025
Version published to 10.1101/2024.08.02.606422 on bioRxiv
Aug 3, 2024
Related articles
Beta-lactam enhancement against methicillin-resistant
Staphylococcus aureus
by cell wall blockade is autolysis-dependent: a butyrolactone derivative as case in point
This article has 7 authors:
Pradnya M. Magdum
Jenny N. Grissom
Brendan T. Franey
Saif Ullah
May H. Abdel Aziz
E. Jeffrey North
Aurijit Sarkar
Isoindole-benzohydrazide derivative potentiates colistin activity to overcome resistance conferred by MCR-1 variants in
Escherichia coli
This article has 3 authors:
Anna S. Wolf
Ruth O. Ndupu
John N. Alumasa
Diversity of penicillin-binding protein 2x in
Streptococcus pyogenes
from England and Wales, 2001 to 2015
This article has 11 authors:
Greta Šveikauskaitė
Asha L Marshall
Sofya Gorshkova
Rebecca L Guy
Yu Wan
Ana Vieira
Juliana Coelho
Kartyk Moganeradj
Shiranee Sriskandan
Elita Jauneikaite
Valerie WC Soo
Site navigation links
Home
Groups
Explore
Newsletter
About
Log In